This week in drug discovery (7-11 April)
News round-up for 7-11 April by DDW Senior Digital Content Editor Diana Spencer.
As the political news brings more uncertainty for the sector, this week we are focusing on positive developments in the field of oncology, from the possibilities of cancer cures in the rainforest, to a new research model that could unlock targeted treatments for lung cancer.
The top stories:
Could a molecule from a rainforest tree treat solid tumour cancers?
Scientists at The Institute of Cancer Research, London, are collaborating with life sciences company QBiotics to understand the molecular and cellular mechanisms of a potential new cancer drug.
EC approves subcutaneous use of J&J antibodies for cancer
The European Commission (EC) has approved an indication extension for two of Johnson & Johnson’s monoclonal antibody therapies in oncology.
Partners develop AI tools to personalise colon cancer treatment
Cancer Research Horizons has announced a collaboration with Histofy to develop tools that predict how colorectal cancer patients respond to different treatment options using the multi-modal S:CORT dataset.
Janssen’s Hait honoured for achievements in cancer research
The 2025 AACR-Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research will be presented to William Hait, Fellow of the AACR Academy, during the AACR Annual Meeting 2025.
Cell-based lung cancer model could unlock targeted treatments
Scientists at the Cancer Research Manchester Institute have created a new model of Lung Squamous Cell Carcinoma (LUSC) to study the development, activity, and vulnerabilities of the disease.